Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Chun Po Yen

Neurological Surgery Charlottesville, VA Medical Doctor

NPI 1700014222 CMS profile 838313

415 Ray C. Hunt Dr, Charlottesville, VA 22903

Open in the dashboard

General payments

$89,976

229 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$814,691 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Chun Po Yen of Charlottesville, VA is reported in the CMS Open Payments database as having received $89,976 across 229 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $814,691 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 90th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,067 28
2024 General $36,706 40
2023 General $7,972 43
2022 General $13,378 20
2021 General $9,162 42
2019 General $14,691 56

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Chun Po Yen
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Chun Po Yen were reported at $8,067. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Chun Po Yen Neurological Surgery median Middle half National median
2019 $14,691 $582 $138–$3,006 $163
2020 $0 $294 $76–$2,174 $114
2021 $9,162 $387 $105–$2,432 $132
2022 $13,378 $542 $139–$2,989 $149
2023 $7,972 $534 $145–$2,697 $160
2024 $36,706 $574 $155–$3,046 $164
2025 $8,067 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Carlsmed, Inc. $39,429 85 payments
  2. NuVasive, Inc. $33,350 93 payments
  3. Life Spine, Inc. $12,434 12 payments
  4. Medtronic, Inc. $3,028 21 payments
  5. Stryker Corporation $1,278 9 payments
  6. Medtronic USA, Inc. $234 3 payments
  7. SI-BONE, Inc. $130 2 payments
  8. Seaspine Orthopedics Corporation $53 2 payments
  9. Orthofix Medical, Inc. $41 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $51,490 19 payments
  2. Travel and Lodging $28,174 73 payments
  3. Food and Beverage $10,311 137 payments
Products named General payments · program years 2019–2025
  1. aprevo Orthopedics/Orthopedic Surgery $30,624 50 payments
  2. XLIF Spine/Spine Surgery $13,924 23 payments
  3. ProLift Lateral $11,466 7 payments
  4. Prolift micro $10,584 1 payment
  5. Centric-S $10,584 1 payment
  6. Pulse Spine/Spine Surgery $10,146 29 payments
  7. Pulse Spine/Spine Surgery $7,182 19 payments
  8. XLIF Spine/Spine Surgery $6,256 23 payments
  9. aprevo Orthopedics/Orthopedic Surgery $4,519 17 payments
  10. TLIF $3,200 4 payments
  11. Other $14,929 94 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 56 billing codes

Paid by Medicare

$199,291

Medicare's payments for the services billed

Medicare patients

234

Average age 73

Services billed

669

130 women, 104 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 33%
Depression 31%
Chronic kidney disease 28%
Ischemic heart disease 25%
Osteoporosis 22%
Atrial fibrillation 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

229 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record